Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00223860 · ClinicalTrials.gov registry record · NA
Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT00223860 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 100 participants.
The verdict
NCT00223860, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
There is evidence that has shown that serum testosterone levels are low in persons with chronic spinal cord injury (SCI). The question arises as to whether the defect in testosterone production is from the hypothalamic pituitary system (part of the brain that plays a role in testosterone release) or from the male testes. Studies to date are inconclusive. This study, will examine if persons with SCI has a normal hormonal regulation of the male hormone testosterone in comparison to persons who are able-bodied. This will help understand the physical and metabolic changes that occur in persons with SCI.
Interventions
- DRUG Human chorionic gonadotropin (hCG)
- DRUG Luteinizing hormone releasing hormone (LHRH)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2001-07 |
| Est. Completion | 2007-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00223860
The ClinicalTrials.gov registry entry for NCT00223860 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Human chorionic gonadotropin (hCG) is the first listed.
NCT00223860 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00223860 about?
NCT00223860 is a clinical study titled "Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.". There is evidence that has shown that serum testosterone levels are low in persons with chronic spinal cord injury (SCI). The question arises as to whether the defect in testosterone production is from the hypothalamic pituitary system (part of the brain that plays a role in testosterone release) or...
What is the current status of trial NCT00223860?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2001-07. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00223860?
The interventions under investigation include: Human chorionic gonadotropin (hCG) (DRUG), Luteinizing hormone releasing hormone (LHRH) (DRUG).
Who is sponsoring clinical trial NCT00223860?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.